HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Rivaroxaban expected to have ‘huge impact’ on management of DVT, PE
• ASH elects four committee members
• 'Checklist' increases physician compliance in ordering prophylaxis for trauma patients
• Cigarette use among youth declined in the past decade Michael B. Steinberg, MD, MPH, FACP
• EPIC: Proton therapy appears highly effective for men with prostate cancer
• Epidemiologist receives IARC award
• Foundation honors ‘Hero for Hope’
• Information guide addresses DVT, PE diagnosis, treatment
• Ohio State names new section chief
• Prognosis may be favorable for HIV-related Hodgkin’s lymphoma
• Watchful waiting still viable option for follicular lymphoma
• Weill Cornell appoints director
• 2012 Hematology Drugs in the Pipeline
• FDA grants priority review for ponatinib
• FDA approves Synribo for patients with CML
• Male veterans, active duty service members in poorer health than civilians
• Nasopharyngeal carcinoma in an HIV-positive patient with cranial nerve defects Munir Ghesani, MD, FACNM; Ippolito Modica, MD; Michael Chung, MD; Esha Gollapalle, MD; Daniel E. Meltzer, MD
• Leadership, training offerings help clinicians improve practice, patient outcomes William Wood, MD
• Aspirin benefited colon cancer patients with key gene mutation
• Aspirin/esomeprazole therapy reduced PGE2 in patients with Barrett’s esophagus
• Brachytherapy led to more complications in older breast cancer patients
• Cancer protein intensifies gene expressions
• Cetuximab conferred benefits regardless of tumor HPV status
• Contrast-enhanced ultrasound identified high-grade prostate cancer
• Genetic variation reduced hospitalizations in children with sickle cell disease
• HIV drug shows activity against HER-2–positive breast cancer
• HLA-haploidentical bone marrow benefited patients with sickle cell disease
• Invasive SCC present in 31% of SCCIS sent for Mohs surgery
• Microtransplantation shows promise as post-remission therapy in AML
• Patients with metastatic RCC who developed hypothyroidism experienced longer PFS
• Proneurotensin may increase risk for CVD, diabetes, breast cancer in women
• Review finds no benefit from routine general health checks
• Smokers with lung cancer have more genetic mutations than never-smokers
• Survival rates for HCC similar for patients with, without HIV infection
• Tumor grade likely detects those with VTE risk
• Vigorous activity briefly raised bleeding risk in youth with hemophilia
• VTE risk greater among RA patients than general population
• Chronic constipation associated with colorectal cancer, benign neoplasms
• Doxepin rinse significantly reduced oral mucositis pain
• Elevated depression, shortened telomeres increased bladder cancer mortality
• Endoscopists frequently overestimated polyp size during colonoscopy
• High BMI linked to adenoma detection at colonoscopy
• Immunosuppressed patients displayed more aggressive nonmelanoma skin cancers
• Memantine delayed cognitive decline in patients undergoing WBRT
• Patients with incurable lung cancer often have unrealistic views of radiation therapy
• RF ablation safe, durable for intramucosal carcinomas in Barrett’s esophagus
• Sildenafil citrate improved sexual function of patients with prostate cancer
• Type 2 diabetes linked to greater risk for Barrett’s esophagus
• Younger age at colorectal cancer diagnosis linked to advanced illness, but improved survival
• VSLI offers exciting therapeutic option for relapsed, refractory ALL Debbie Blamble, PharmD, BCOP